Laura J Davidson, Gilbert H L Tang, Edwin C Ho, Marat Fudim, Tiberio Frisoli, Anton Camaj, Margaret T Bowers, Sofia Carolina Masri, Pavan Atluri, Joanna Chikwe, Peter J Mason, Jason C Kovacic, George D Dangas
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options...
April 25, 2024: Circulation